<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media - Thanaviratananich, S - 2013 | Cochrane Library</title> <meta content="Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media - Thanaviratananich, S - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004975.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media - Thanaviratananich, S - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004975.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004975.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media" name="citation_title"/> <meta content="Sanguansak Thanaviratananich" name="citation_author"/> <meta content="Faculty of Medicine, Khon Kaen University" name="citation_author_institution"/> <meta content="sthanaviratananich@gmail.com" name="citation_author_email"/> <meta content="Malinee Laopaiboon" name="citation_author"/> <meta content="Khon Kaen University" name="citation_author_institution"/> <meta content="Patravoot Vatanasapt" name="citation_author"/> <meta content="Faculty of Medicine, Khon Kaen University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD004975.pub3" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/12/13" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004975.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004975.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004975.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Disease; Amoxicillin [*administration &amp; dosage]; Anti‐Bacterial Agents [*administration &amp; dosage]; Clavulanic Acid [*administration &amp; dosage]; Drug Administration Schedule; Drug Therapy, Combination [methods]; Otitis Media [*drug therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004975.pub3&amp;doi=10.1002/14651858.CD004975.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="k5rEBE5b";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004975\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004975\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004975.pub3",title:"Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media",firstPublishedDate:"Dec 13, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=k5rEBE5b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004975.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004975.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004975.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004975.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004975.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004975.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004975.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004975.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004975.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004975.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>26415 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004975.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-sec-0086"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-sec-0058"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-sec-0080"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/appendices#CD004975-sec-0091"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/table_n/CD004975StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/table_n/CD004975StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/information#CD004975-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Sanguansak Thanaviratananich</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/information#CD004975-cr-0003">Malinee Laopaiboon</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004975.pub3/information#CD004975-cr-0004">Patravoot Vatanasapt</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/information/en#CD004975-sec-0105">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 13 December 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004975.pub3">https://doi.org/10.1002/14651858.CD004975.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004975-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004975-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004975-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004975-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004975-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004975-abs-0001" lang="en"> <section id="CD004975-sec-0001"> <h3 class="title" id="CD004975-sec-0001">Background</h3> <p>Acute otitis media (AOM) is a common problem in children, for which amoxicillin, with or without clavulanate, is frequently prescribed as a treatment of choice. The conventional recommendation is either three or four daily doses. However, nowadays it is frequently prescribed as once or twice daily doses. If once or twice daily amoxicillin, with or without clavulanate, is as effective for acute otitis media as three or four times a day, it may be more convenient to give the medication once or twice a day to children and hence improve compliance. </p> </section> <section id="CD004975-sec-0002"> <h3 class="title" id="CD004975-sec-0002">Objectives</h3> <p>To compare the effectiveness of one or two daily doses with three or four daily doses of amoxicillin, with or without clavulanate, for the treatment of AOM in children; and to compare complication rates and adverse reactions. </p> </section> <section id="CD004975-sec-0003"> <h3 class="title" id="CD004975-sec-0003">Search methods</h3> <p>We searched CENTRAL 2013, Issue 2, MEDLINE (January 1950 to March week 1, 2013), EMBASE (1974 to March 2013) and the Science Citation Index (2001 to March 2013). </p> </section> <section id="CD004975-sec-0004"> <h3 class="title" id="CD004975-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) of children aged 12 years or younger with AOM, diagnosed by acute ear pain (otalgia) and inflamed ear drum (confirmed by positive tympanocentesis or tympanogram of type B or C). </p> </section> <section id="CD004975-sec-0005"> <h3 class="title" id="CD004975-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data on treatment outcomes from individual trials and assessed trial quality based on selection bias, performance bias and detection bias, attrition bias, reporting bias and other biases. We defined the quality grading as low risk of bias, high risk of bias or unclear risk of bias. We summarised the results as risk ratio (RR) with 95% confidence intervals (CI). </p> </section> <section id="CD004975-sec-0006"> <h3 class="title" id="CD004975-sec-0006">Main results</h3> <p>We included five studies with 1601 children in the review. Pooled analysis demonstrated that the following outcomes were comparable between the two groups: clinical cure at the end of therapy (RR 1.03, 95% CI 0.99 to 1.07); during therapy (RR 1.06, 95% CI 0.85 to 1.33) and at follow‐up (RR 1.02, 95% CI 0.95 to 1.09); recurrent AOM (RR 1.21, 95% CI 0.52 to 2.81); compliance rate (RR 1.04, 95% CI 0.98 to 1.10) and overall adverse events (RR 0.92, 95% CI 0.52 to 1.63). When we performed subgroup analysis separately for trials with amoxicillin only and amoxicillin/clavulanate only, it showed that all important outcomes were comparable between once or twice daily groups and the three times daily group. The risk of bias amongst the five included studies was as follows: for random sequence generation we graded two studies as low and three unclear risk of bias; for allocation concealment all studies were at unclear risk of bias; for blinding (performance and detection bias) we graded four as high and one as unclear risk of bias; for incomplete outcome data (attrition bias) we graded two low, two high and one as unclear risk of bias; for reporting bias four were at low and one at high risk; and for ‘other’ bias four were at low and one at unclear risk of bias. </p> </section> <section id="CD004975-sec-0007"> <h3 class="title" id="CD004975-sec-0007">Authors' conclusions</h3> <p>This review showed that the results of using once or twice daily doses of amoxicillin, with or without clavulanate, were comparable with three doses for the treatment of AOM. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004975-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004975-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004975-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004975-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004975-abs-0004">Français</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004975-abs-0003" lang="en"> <h3>Dosage intervals of amoxicillin for the treatment of acute middle ear infection</h3> <p>Acute middle ear infection (acute otitis media) is a very common disease in children and may cause pain and hearing loss. Delayed or ineffective treatment may lead to serious complications such as ear drum perforation, sensorineural hearing loss or the disease becoming chronic. Amoxicillin, with or without clavulanate, is the most commonly used antibiotic for treating acute otitis media. Currently, a reduction in the dosing interval to one or two daily doses is being used, in preference to the conventional three or four daily doses, to aid compliance. </p> <p>We identified five randomised clinical studies with 1601 children comparing two dosing schedules. Participants were aged 12 years or younger with AOM. The primary outcome was clinical cure rate in terms of resolution of otalgia and fever at the end of antibiotic therapy (days seven to 15). The secondary outcomes were clinical cure rate in terms of middle ear effusion during therapy, clinical cure rate post‐treatment (one to three months) in terms of resolution of middle ear infection, AOM complications and adverse events to medication. The results showed that treating acute middle ear infection with either once/twice daily or three times daily amoxicillin, with or without clavulanate, has the same results using our outcome measures, including adverse events such as diarrhoea and skin reactions. </p> <p>The evidence is current to March 2013.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004975-sec-0086" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004975-sec-0086"></div> <h3 class="title" id="CD004975-sec-0087">Implications for practice</h3> <section id="CD004975-sec-0087"> <p>In routine practice amoxicillin with/without clavulanate has been used as a twice daily dose for the treatment of AOM and other infectious diseases of the upper respiratory tract. Our findings confirm that using twice daily doses has the same effectiveness as thrice daily doses for uncomplicated AOM. </p> </section> <h3 class="title" id="CD004975-sec-0088">Implications for research</h3> <section id="CD004975-sec-0088"> <p>More than 90% of AOM cases occur in children less than two years of age. However, in all of the included studies the age ranges were between two months and 12 years, with few cases less than two years of age. A good quality equivalence or non‐inferiority trial should be performed to see whether the treatments are either equally effective or whether a lower dosage scheme is as effective as a higher dosage scheme. Children less than two years of age should also be included in the study and a microbiological study of middle ear fluid should be performed. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004975-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004975-sec-0022"></div> <section id="CD004975-sec-0023"> <h3 class="title" id="CD004975-sec-0023">Description of the condition</h3> <p>Acute otitis media (AOM) is one of the most common diseases in children. During the first six months of life about 48% of infants have one episode of AOM or otitis media with effusion (OME) and about 20% have two or more episodes (<a href="./references#CD004975-bbs2-0011" title="DalyKA , BrownJE , LindgrenBR , MelandMH , LeCT , GiebinkGS . Epidemiology of otitis media onset by six months of age. Pediatrics1999;103(6 pt 1):1158‐66. [PUBMED: 10353923] ">Daly 1999</a>). The peak incidence of AOM occurs between 6 and 12 months of age. It has been found that by the end of the first year of life 62.4% of infants have had one or more episodes of AOM and 17.3% have had three or more episodes (<a href="./references#CD004975-bbs2-0033" title="TeeleDW , KleinJO , RosnerB . Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. Journal of Infectious Diseases1989;160(1):83‐94. [PUBMED: 2732519] ">Teele 1989</a>). The risk of developing another episode within one month after the onset of the primary infection is estimated at 35% (<a href="./references#CD004975-bbs2-0009" title="CarlinSA , MarchantCD , ShurinPA , JohnsonCE , Murdell‐PanekD , BarenkampSJ . Early recurrences of otitis media: reinfection or relapse?. Journal of Pediatrics1987;110(1):20‐5. [PUBMED: 3540247] ">Carlin 1987</a>). </p> <p>The common bacterial pathogens of AOM are <i>Streptococcal pneumoniae</i> (<i>S. pneumoniae</i> ), <i>Haemophilus influenzae</i> (<i>H. influenzae</i> ) and <i>Moraxella catarrhalis</i> (<i>M. catarrhalis</i>) (<a href="./references#CD004975-bbs2-0019" title="JacobsMR , DaganR , AppelbaumPC , BurchDJ . Prevalence of antimicrobial‐resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrobial Agents and Chemotherapy1998;42(3):589‐95. [PUBMED: 9517937] ">Jacobs 1998</a>). These bacteria are becoming increasingly resistant to antibiotics (<a href="./references#CD004975-bbs2-0008" title="BarnettED , KleinJO . The problem of resistant bacteria for the management of acute otitis media. Pediatric Clinics of North America1995;42(3):509‐17. [PUBMED: 7761138] ">Barnett 1995</a>; <a href="./references#CD004975-bbs2-0014" title="FadenH , DoernG , WolfJ , BlockerM . Antimicrobial susceptibility of nasopharyngeal isolates of potential pathogens recovered from infants before antibiotic therapy: implications for the management of otitis media. Pediatric Infectious Diseases Journal1994;13(7):609‐12. [PUBMED: 7970948] ">Faden 1994</a>; <a href="./references#CD004975-bbs2-0017" title="HendersonFW , GilliganPH , WaitK , GoffDA . Nasopharyngeal carriage of antibiotic‐resistant pneumococci by children in group day care. Journal of Infectious Diseases1988;157:256‐63. [PUBMED: 3257247] ">Henderson 1988</a>; <a href="./references#CD004975-bbs2-0020" title="JohnsonAP , SpellerDC , GeorgeRC , WarnerM , DomingueG , EfstratiouA . Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995. BMJ1996;312:1454‐6. [PUBMED: 8664623] ">Johnson 1996</a>; <a href="./references#CD004975-bbs2-0021" title="KaplanSL . The emergence of resistant pneumococcus as a pathogen in childhood upper respiratory infections. Seminars in Respiratory Infections1995;10:31‐6. [PUBMED: 7761712 ] ">Kaplan 1995</a>). Systematic reviews have demonstrated that in uncomplicated AOM, about 20 children must be treated with antibiotics to prevent one child having some pain after two days (<a href="./references#CD004975-bbs2-0035" title="VenekampRP , SandersS , GlasziouPP , DelMarCB , RoversMM . Antibiotics for acute otitis media in children. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD000219.pub3] ">Venekamp 2013</a>) and about eight children must receive antibiotics to avoid one clinical failure (<a href="./references#CD004975-bbs2-0030" title="RosenfeldRM , CasselbrantML , HannleyMT . Implications of the AHRQ evidence report on acute otitis media. Otolaryngology ‐ Head and Neck Surgery2001;125(5):440‐8. [PUBMED: 14608265] ">Rosenfeld 2001</a>). A study by <a href="./references#CD004975-bbs2-0032" title="RoversMM , GlasziouP , AppelmanCL , BurkeP , McCormickDP , DamoiseauxRA , et al. Antibiotics for acute otitis media: a meta‐analysis with individual patient data. Lancet2006;368(9545):1429‐35. [PUBMED: 17055944] ">Rovers 2006</a> demonstrated that antibiotics seemed to have most benefit in children younger than two years of age with bilateral AOM, and in children with both AOM and otorrhoea. However, the emergence of multiple‐drug resistant strains, particularly <i>S. pneumoniae</i>, complicates the management of AOM and increases the risk of treatment failure. Antibiotics are frequently used for AOM in the US (<a href="./references#CD004975-bbs2-0015" title="FroomJ , CulpepperL , JacobsM , DeMelkerRA , GreenLA , vanBuchemL , et al. Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ1997;315(7100):98‐102. [PUBMED: 9240050] ">Froom 1997</a>; <a href="./references#CD004975-bbs2-0035" title="VenekampRP , SandersS , GlasziouPP , DelMarCB , RoversMM . Antibiotics for acute otitis media in children. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD000219.pub3] ">Venekamp 2013</a>), where it is the most frequent disease that antibiotics are used to treat in outpatient departments (<a href="./references#CD004975-bbs2-0026" title="McCaigLF , HughesJM . Trends in antimicrobial drug prescribing among of office‐based physicians the United States. JAMA1995;273:214‐9. [PUBMED: 7807660] ">McCaig 1995</a>). In contrast, the national Dutch guidelines recommend that children be treated for symptoms but do not receive antibiotics unless fever or pain persists (<a href="./references#CD004975-bbs2-0015" title="FroomJ , CulpepperL , JacobsM , DeMelkerRA , GreenLA , vanBuchemL , et al. Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ1997;315(7100):98‐102. [PUBMED: 9240050] ">Froom 1997</a>). </p> </section> <section id="CD004975-sec-0024"> <h3 class="title" id="CD004975-sec-0024">Description of the intervention</h3> <p>Due to growing bacterial resistance, the Center for Disease Control and Prevention and the American Academy of Pediatrics promotes the judicious use of antibiotics in the treatment of AOM. Antibiotic therapy remains an appropriate treatment option for most children with AOM because spontaneous cure rates are lower in complicated AOM and AOM secondary to <i>S. pneumoniae</i> infection. When amoxicillin, the treatment of choice in AOM, is not effective or not tolerated in children, an alternative antibiotic such as amoxicillin/clavulanate, or second‐ and third‐generation cephalosporins, which can cover beta‐lactamase producing bacteria, should be considered (<a href="./references#CD004975-bbs2-0028" title="PichicheroME , CaseyJR . Acute otitis media disease management. Minerva Pediatrica2003;55(5):415‐38. [PUBMED: 14608265] ">Pichichero 2003</a>). </p> <p>The effectiveness of antibiotics does not depend solely on their antimicrobial activity against the suspected pathogens, but also on characteristics such as dosage, appropriate dosing intervals, tolerability and palatability, which promote compliance and adherence. A convenient once‐ or twice‐daily dosing schedule increases the likelihood of compliance with a full course of therapy (<a href="./references#CD004975-bbs2-0024" title="LeibovitzE . Acute otitis media in pediatric medicine: current issues in epidemiology, diagnosis, and management. Paediatric Drugs2003;5(Suppl 1):1‐12. [PUBMED: 14632101] ">Leibovitz 2003</a>). The traditional dosing interval for prescribing amoxicillin, with or without clavulanate, is every six to eight hours. These dosing intervals may result in poor compliance especially for children at school or daycare centres, which necessitates the involvement and co‐operation of a third person. </p> </section> <section id="CD004975-sec-0025"> <h3 class="title" id="CD004975-sec-0025">How the intervention might work</h3> <p>The length of time that antibiotic serum levels are above the Minimal Inhibitory Concentration (MIC), or time above the MIC, has been demonstrated to be a major determinant in predicting successful clinical outcomes for beta‐lactam antimicrobial agents (<a href="./references#CD004975-bbs2-0010" title="CarsO . Efficacy of beta‐lactam antibiotics: integration of pharmacokinetics and pharmacodynamics. Diagnostic Microbiology and Infectious Disease1997;27:29‐33. [PUBMED: 9127103] ">Cars 1997</a>; <a href="./references#CD004975-bbs2-0012" title="DrusanoGL , CraigWA . Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. Journal of Chemotherapy1997;9(Suppl 3):38‐44. [PUBMED: 9248979] ">Drusano 1997</a>). This finding denotes that the dosing frequency of beta‐lactam antimicrobial agents could be reduced by increasing the dose, in order to maximise time above the MIC. An increased dose, instead of three times daily dosing, will enhance compliance (<a href="./references#CD004975-bbs2-0016" title="GrobPR . Antibiotic prescribing practices and patient compliance in the community. Scandinavian Journal of Infectious Diseases ‐ Supplementum1992;83:7‐14. [PUBMED: 1488629] ">Grob 1992</a>; <a href="./references#CD004975-bbs2-0034" title="UrquhartJ . Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgraduate Medical Journal1992;68(Suppl 3):49‐58. [PUBMED: 1287619] ">Urquhart 1992</a>). However, these studies relate to conditions other than otitis media. </p> </section> <section id="CD004975-sec-0026"> <h3 class="title" id="CD004975-sec-0026">Why it is important to do this review</h3> <p>In recent years, an increased dosing interval of amoxicillin, with or without clavulanate, has been more frequently used to treat AOM (<a href="./references#CD004975-bbs2-0007" title="American Academy of Pediatrics Subcommittee. Diagnosis and management of acute otitis media. Pediatrics2004;113:1451‐65. [PUBMED: 15121972] ">AAPS 2004</a>). It is therefore reasonable to assess clinical trials comparing the effectiveness of reduced dosing intervals (one or two daily doses) with traditional dosing intervals (three or four daily doses) of amoxicillin, with or without clavulanate, for the treatment of AOM in children. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004975-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004975-sec-0027"></div> <p>To compare the effectiveness of one or two daily doses with three or four daily doses of amoxicillin, with or without clavulanate, for the treatment of AOM in children; and to compare complication rates and adverse reactions. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004975-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004975-sec-0028"></div> <section id="CD004975-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004975-sec-0030"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) comparing two different dosing intervals of the same intervention, amoxicillin, with or without clavulanate. </p> </section> <section id="CD004975-sec-0031"> <h4 class="title">Types of participants</h4> <p>Participants aged 12 years or younger, with AOM diagnosed by acute ear pain (otalgia) and an inflamed ear drum (confirmed by positive tympanocentesis or tympanogram of type B or C). A tympanogram is the print‐out of an impedance bridge showing the stiffness or the compliance of the middle ear structures as it varies with changes in pressure within the external ear canal. A type B tympanogram suggests fluid in the middle ear; type C suggests that the pressure within the middle ear is below atmospheric pressure. </p> </section> <section id="CD004975-sec-0032"> <h4 class="title">Types of interventions</h4> <p>Once or twice daily doses compared with three or four daily doses of amoxicillin, with or without clavulanate. </p> </section> <section id="CD004975-sec-0033"> <h4 class="title">Types of outcome measures</h4> <section id="CD004975-sec-0034"> <h5 class="title">Primary outcomes</h5> <p>Clinical cure rate at the end of antibiotic therapy (days 7 to 15), in terms of resolution of otalgia, resolution of fever and bacteriological cure rate, if data are provided. </p> </section> <section id="CD004975-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD004975-list-0001"> <li> <p>Clinical cure rate during therapy in terms of resolution of otalgia and resolution of fever. </p> </li> <li> <p>Clinical cure rate post‐treatment (one to three months), in terms of resolution of middle ear effusion, as determined by tympanometry, assessed only in those who do not have recurrences of AOM after completion of therapy. </p> </li> <li> <p>AOM complications: recurrent AOM (after completion of therapy), acute mastoiditis.</p> </li> <li> <p>Adverse reactions to medication.</p> </li> </ol> </p> </section> </section> </section> <section id="CD004975-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004975-sec-0037"> <h4 class="title">Electronic searches</h4> <p>For this update we searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2013, Issue 2, part of <i>The Cochrane Library</i>, www.thecochranelibrary.com (accessed 15 March 2013), which contains the Acute Respiratory Infections (ARI) Group's Specialised Register, MEDLINE (January 1950 to March week 1, 2013), EMBASE (July 2010 to August 2012) and the Science Citation Index (2001 to March 2013). See <a href="./appendices#CD004975-sec-0092">Appendix 1</a> for details of previous search. </p> <p>We used the following terms to search MEDLINE and CENTRAL. We combined the MEDLINE search with the Cochrane highly sensitive search strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision): Ovid format (<a href="./references#CD004975-bbs2-0023" title="LefebvreC , ManheimerE , GlanvilleG . Chapter 6: Searching for studies. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. Chichester, UK: Wiley‐Blackwell, 2011. ">Lefebvre 2011</a>). We adapted the search strategy to search other databases. See <a href="./appendices#CD004975-sec-0097">Appendix 2</a> for the EMBASE search strategy and <a href="./appendices#CD004975-sec-0098">Appendix 3</a> for the Science Citation Index search strategy. </p> <section id="CD004975-sec-0038"> <h5 class="title">MEDLINE (OVID)</h5> <p>1 exp Otitis Media/<br/> 2 otitis media.tw.<br/> 3 (AOM or OME).tw.<br/> 4 ((infect* or inflam*) adj2 middle ear*).tw.<br/> 5 or/1‐4<br/> 6 exp Amoxicillin/<br/> 7 (amoxicillin* or amoxycillin*).tw,nm.<br/> 8 6 or 7<br/> 9 5 and 8 </p> </section> </section> <section id="CD004975-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of identified clinical trials and any relevant reviews or meta‐analyses. We contacted major pharmaceutical companies that manufacture antibiotics and relevant experts in the field for additional trial information. We contacted the first author of relevant trials if any questions arose. </p> </section> </section> <section id="CD004975-sec-0040"> <h3 class="title" id="CD004975-sec-0040">Data collection and analysis</h3> <section id="CD004975-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Two review authors (ST, PV) retrieved titles and abstracts from the literature search for checking against the inclusion/exclusion criteria and recorded data on a pre‐designed screening form. The same review authors independently screened results for each title/abstract. A third review author (ML) resolved any disagreements. We requested the full‐text articles if the title or the abstract were unclear. </p> </section> <section id="CD004975-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (ST, PV) independently reviewed each article and completed data extraction forms. We resolved disagreements through group discussion. </p> </section> <section id="CD004975-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the methodological quality of the selected trials using the criteria described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004975-bbs2-0018" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). The methods used for the generation of the randomisation sequence were described for each trial. </p> <section id="CD004975-sec-0044"> <h5 class="title">1. Random sequence generation</h5> <p>We assessed the possibility of selection bias for random sequence generation, using the following criteria: </p> <p> <ul id="CD004975-list-0002"> <li> <p>'Low' risk of bias: description of a random component in the sequence generation process was shown. </p> </li> <li> <p>'High' risk of bias: the investigators describe a non‐random component in the sequence generation process such as randomisation based on date of birth, case record number or date of presentation. </p> </li> <li> <p>'Unclear' risk of bias: insufficient information about the sequence generation process to permit a judgement of 'Low' risk or 'High' risk. </p> </li> </ul> </p> </section> <section id="CD004975-sec-0045"> <h5 class="title">2. Allocation sequence concealment</h5> <p> <ul id="CD004975-list-0003"> <li> <p>'Low' risk of bias: participants and investigators enrolling participants could not foresee assignment due to central allocation, sequentially numbered drug containers of identical appearance, sequentially numbered, opaque, sealed envelopes. </p> </li> <li> <p>'High' risk of bias: participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias. </p> </li> <li> <p>'Unclear' risk of bias: insufficient information about the allocation concealment to permit a judgement of 'Low' risk or 'High' risk. </p> </li> </ul> </p> </section> <section id="CD004975-sec-0046"> <h5 class="title">3. Blinding (performance bias and detection bias)</h5> <p> <ul id="CD004975-list-0004"> <li> <p>'Low' risk of bias: any one of the following:</p> <ul id="CD004975-list-0005"> <li> <p>No blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding. </p> </li> <li> <p>Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken. </p> </li> </ul> </li> <li> <p>'High' risk of bias: any one of the following:</p> <ul id="CD004975-list-0006"> <li> <p>No blinding or incomplete blinding, but the review authors judge that the outcome is likely to be influenced by lack of blinding. </p> </li> <li> <p>Blinding of participants and key study personnel attempted, and likely that the blinding could have been broken, and the outcome is likely to be influenced by lack of blinding. </p> </li> </ul> </li> <li> <p>'Unclear' risk of bias: any of the following:</p> <ul id="CD004975-list-0007"> <li> <p>Insufficient information to permit a judgement of 'Low' risk or 'High' risk.</p> </li> <li> <p>The study did not address this outcome.</p> </li> </ul> </li> </ul> </p> </section> <section id="CD004975-sec-0047"> <h5 class="title">4. Incomplete outcome data</h5> <p> <ul id="CD004975-list-0008"> <li> <p>'Low' risk of bias: any one of the following:</p> <ul id="CD004975-list-0009"> <li> <p>No missing outcome data.</p> </li> <li> <p>Reasons for missing outcome data unlikely to be related to true outcome.</p> </li> <li> <p>Missing outcome data balanced in number across intervention groups, with similar reasons for missing data across groups. </p> </li> <li> <p>For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate. </p> </li> <li> <p>For continuous outcome data, plausible effect size among missing outcomes not enough to have a clinically relevant impact on observed effect size. </p> </li> <li> <p>Missing data have been imputed using appropriate methods.</p> </li> </ul> </li> <li> <p>'High' risk of bias: any one of the following:</p> <ul id="CD004975-list-0010"> <li> <p>Reasons for missing outcome data likely to be related to true outcome with either imbalance in numbers or reasons for missing data across intervention groups. </p> </li> <li> <p>For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate. </p> </li> <li> <p>For continuous outcome data, plausible effect size among missing outcomes enough to induce clinically relevant bias in observed effect size. </p> </li> <li> <p>'As‐treated' analysis done with substantial departure of the intervention received from that assigned at randomisation. </p> </li> <li> <p>Potentially inappropriate application of simple imputation.</p> </li> </ul> </li> <li> <p>'Unclear' risk of bias: any one of the following:</p> <ul id="CD004975-list-0011"> <li> <p>Insufficient reporting of attrition/exclusions to permit a judgement of 'Low' risk or 'High' risk (e.g. number randomised not stated, no reasons for missing data provided). </p> </li> <li> <p>The study did not address this outcome.</p> </li> </ul> </li> </ul> </p> </section> <section id="CD004975-sec-0048"> <h5 class="title">5. Selective outcome reporting</h5> <p> <ul id="CD004975-list-0012"> <li> <p>'Low' risk of bias: any of the following:</p> <ul id="CD004975-list-0013"> <li> <p>The study protocol is available and all of the study's pre‐specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre‐specified way. </p> </li> <li> <p>The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre‐specified (convincing text of this nature may be uncommon). </p> </li> </ul> </li> <li> <p>'High' risk of bias: any of the following:</p> <ul id="CD004975-list-0014"> <li> <p>Not all of the study's pre‐specified primary outcomes have been reported.</p> </li> <li> <p>One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre‐specified. </p> </li> <li> <p>One or more reported primary outcomes were not pre‐specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect). </p> </li> <li> <p>One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta‐analysis. </p> </li> <li> <p>The study report fails to include results for a key outcome that would be expected to have been reported for such a study. </p> </li> </ul> </li> <li> <p>'Unclear' risk of bias: insufficient information to permit a judgement of 'Low' risk or 'High' risk. It is likely that the majority of studies will fall into this category. </p> </li> </ul> </p> </section> <section id="CD004975-sec-0049"> <h5 class="title">6. Other bias</h5> <p> <ul id="CD004975-list-0015"> <li> <p>'Low' risk of bias: the study appears to be free of other sources of bias.</p> </li> <li> <p>'High' risk of bias: there is at least one important risk of bias. For example, the study: </p> <ul id="CD004975-list-0016"> <li> <p>had a potential source of bias related to the specific study design used; or</p> </li> <li> <p>has been claimed to have been fraudulent; or</p> </li> <li> <p>had some other problem</p> </li> </ul> </li> <li> <p>'Unclear' risk of bias: there may be a risk of bias, but there is either:</p> <ul id="CD004975-list-0017"> <li> <p>insufficient information to assess whether an important risk of bias exists; or</p> </li> <li> <p>insufficient rationale or evidence that an identified problem will introduce bias.</p> </li> </ul> </li> </ul> </p> </section> </section> <section id="CD004975-sec-0050"> <h4 class="title">Measures of treatment effect</h4> <p>For categorical data (for example, cure or not cure), we used risk ratios (RR) and 95% confidence intervals (CI). We showed continuous differences between groups in the meta‐analysis (for example, pain relief on a visual analogue scale) as a mean difference (MD) and 95% CI. </p> </section> <section id="CD004975-sec-0051"> <h4 class="title">Unit of analysis issues</h4> <p>We did not find any cluster‐randomised trials.</p> </section> <section id="CD004975-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>We performed data analysis using the intention‐to‐treat (ITT) principle. Regarding drop‐outs, we applied the worst‐case scenario to the once or twice daily groups. </p> </section> <section id="CD004975-sec-0053"> <h4 class="title">Assessment of heterogeneity</h4> <p>When important heterogeneity was suspected from the Chi<sup>2</sup> test for heterogeneity (at 10%), or from visual inspection of the results, we investigated this by looking for differences in clinical and methodological factors between the trials. When concern about heterogeneity persisted, we considered using a random‐effects model. We calculated the I<sup>2</sup> statistic to estimate the degree of heterogeneity. If the I<sup>2</sup> statistic was more than 50% or the P value less than 0.10, we used a random‐effects model. </p> </section> <section id="CD004975-sec-0054"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to examine publication bias by using funnel plots (<a href="./references#CD004975-bbs2-0025" title="LightRJ , PillemerDB . Summing Up: The Science of Reviewing Research. Cambridge, Massachusetts: Harvard University Press, 1984. ">Light 1984</a>) and when asymmetry was observed, we would use the trim and fill method to assess the effect of this asymmetry on the conclusions (<a href="./references#CD004975-bbs2-0013" title="DuvalS , TweedieR . Trim and fill: a simple funnel‐plot‐based method of testing and adjusting for publication bias in meta‐analysis. Biometrics2000;56(2):455‐63. [PUBMED: 10877304] ">Duval 2000</a>). However, we did not produce the funnel plots because there were only six studies. When meta‐analysis was inappropriate, we drew conclusions from the trials' descriptive elements, methodological quality, the number of trials with consistent findings, the plausibility of the results and the strength of the associations in the primary trials, as well as consensus among the authors. </p> </section> <section id="CD004975-sec-0055"> <h4 class="title">Data synthesis</h4> <p>We performed meta‐analyses of the five studies (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>) using Review Manager (<a href="./references#CD004975-bbs2-0029" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>) software. </p> </section> <section id="CD004975-sec-0056"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed subgroup analyses and investigated heterogeneity on the basis of types of interventions (i.e. amoxicillin alone (<a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>), amoxicillin with clavulanate (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>)). </p> </section> <section id="CD004975-sec-0057"> <h4 class="title">Sensitivity analysis</h4> <p>We carried out sensitivity analyses to explore the effect of trial quality on the review's conclusions. Analysis of trial quality was based on allocation concealment. We excluded trials with clearly inadequate allocation concealment to assess differences in the overall result. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004975-sec-0058" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004975-sec-0058"></div> <section id="CD004975-sec-0059"> <h3 class="title">Description of studies</h3> <section id="CD004975-sec-0060"> <h4 class="title">Results of the search</h4> <p>The MEDLINE search retrieved 171 studies. However, there were only six studies relevant to the objectives of this review (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0006" title="JacobssonS , FoghA , LarssonA , LomborgS . Evaluation of amoxicillin clavulanate twice daily versus thrice daily in the treatment of otitis media in children. Danish‐Swedish Study Group. European Journal of Clinical Microbiology and Infectious Diseases1993;12(5):319‐24. [MEDLINE: 8354296] ">Jacobsson 1993</a>; <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>). Among the 229 results retrieved by the EMBASE search, six relevant studies were found (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0006" title="JacobssonS , FoghA , LarssonA , LomborgS . Evaluation of amoxicillin clavulanate twice daily versus thrice daily in the treatment of otitis media in children. Danish‐Swedish Study Group. European Journal of Clinical Microbiology and Infectious Diseases1993;12(5):319‐24. [MEDLINE: 8354296] ">Jacobsson 1993</a>; <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>). No randomised controlled trial (RCT) was retrieved by searching the Science Citation Index. We found six studies in health services research meeting abstracts but only one was relevant to the review objectives (<a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>). We retrieved six out of 98 studies from the CENTRAL search (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0006" title="JacobssonS , FoghA , LarssonA , LomborgS . Evaluation of amoxicillin clavulanate twice daily versus thrice daily in the treatment of otitis media in children. Danish‐Swedish Study Group. European Journal of Clinical Microbiology and Infectious Diseases1993;12(5):319‐24. [MEDLINE: 8354296] ">Jacobsson 1993</a>; <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>). </p> </section> <section id="CD004975-sec-0061"> <h4 class="title">Included studies</h4> <p>We included five studies involving 1601 children (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>). </p> <p>Four studies were supported by pharmaceutical funding (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>). Two trials compared amoxicillin without clavulanate (<a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>) and used once and two daily versus three times daily dosing, while the other four studies compared the effectiveness of amoxicillin/clavulanate two times versus three times daily (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0006" title="JacobssonS , FoghA , LarssonA , LomborgS . Evaluation of amoxicillin clavulanate twice daily versus thrice daily in the treatment of otitis media in children. Danish‐Swedish Study Group. European Journal of Clinical Microbiology and Infectious Diseases1993;12(5):319‐24. [MEDLINE: 8354296] ">Jacobsson 1993</a>). Treatment duration was 10 days in four trials (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>) and 7 to 10 days in one trial (<a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>). </p> </section> <section id="CD004975-sec-0062"> <h4 class="title">Excluded studies</h4> <p>We excluded the study by Jacobsson (<a href="./references#CD004975-bbs2-0006" title="JacobssonS , FoghA , LarssonA , LomborgS . Evaluation of amoxicillin clavulanate twice daily versus thrice daily in the treatment of otitis media in children. Danish‐Swedish Study Group. European Journal of Clinical Microbiology and Infectious Diseases1993;12(5):319‐24. [MEDLINE: 8354296] ">Jacobsson 1993</a>) because it included only recurrent AOM cases or cases that were not responsive to amoxicillin/penicillin or cefaclor, which differed from the other studies. In addition, the total daily dosage for amoxicillin was quite low (20 to 33.2 mg/kg/day). </p> </section> </section> <section id="CD004975-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>The included studies are summarised in the <a href="./references#CD004975-sec-0110" title="">Characteristics of included studies</a> tables and the quality assessment of each study is summarised in 'Risk of bias' tables. The detailed risks of bias and quality of each study is shown in <a href="#CD004975-tbl-0001">Table 1</a>. We found that all trials had unclear risk of bias for allocation concealment. A graphical representation of risk of bias among the included studies is shown in <a href="#CD004975-fig-0001">Figure 1</a>. A funnel plot is shown in <a href="#CD004975-fig-0002">Figure 2</a> which shows that there was no publication bias. </p> <div class="figure" id="CD004975-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004975-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD004975-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Funnel plot of the five trials included." data-id="CD004975-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of the five trials included.</p> </div> </div> </div> <div class="table" id="CD004975-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Quality assessment for individual trials</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Randomisation process</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Allocation concealment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Blinding</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incomplete outcome data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective reporting</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Other bias</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Drop‐outs</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.8% to 8.2%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.2% to 5.6%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.7% to 11%</p> </td> </tr> </tbody> </table> </div> <section id="CD004975-sec-0064"> <h4 class="title">Allocation</h4> <p>All five studies claimed that they were RCTs but only two studies clearly mentioned the method of randomisation (<a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>). One used a computer generation method (<a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>) and the other generated a table of random numbers (<a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>). All studies had an unclear risk of bias because there was no information on the method of allocation concealment. </p> </section> <section id="CD004975-sec-0065"> <h4 class="title">Blinding</h4> <p>There was only one study that had a placebo control and the investigator, participants and assessors were blinded to this (<a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>). Two studies blinded only the observers (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>). There was no information on blinding process in one study (<a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>). </p> </section> <section id="CD004975-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>There was one study with no drop‐outs (<a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>). Three studies had less than 10% drop‐outs (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>) and one study had more than 10% drop‐outs (<a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>). There were three studies with high risk of incomplete outcome data (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>). Two studies with low risk of bias (<a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>) and one study with unclear risk of bias (<a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>). </p> </section> <section id="CD004975-sec-0067"> <h4 class="title">Selective reporting</h4> <p>Four studies had important clinical outcomes (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>), except one study which had high risk of bias for selective reporting (<a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>). Four trials assessed the primary outcome at the end of treatment (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>), while <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> assessed the primary outcome at the follow‐up visit, days 32 to 38. Thus we used the secondary outcome (clinical response at days 12 to 14) by Hoberman as the primary outcome in this review and vice versa. The study by <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a> did not reported clinical cure rate at follow‐up (post‐treatment), including AOM complications. </p> </section> <section id="CD004975-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <p>Four studies reported comparable baseline characteristics and compliance rates for both treatment and control groups (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>). However, the study by <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> did not report compliance rates. </p> </section> </section> <section id="CD004975-sec-0069"> <h3 class="title" id="CD004975-sec-0069">Effects of interventions</h3> <p>We analysed the effectiveness of the interventions based on one or two daily doses of amoxicillin, with or without clavulanate versus three daily doses. Subgroup analyses were performed based on amoxicillin treatment trials only, amoxicillin/clavulanate treatment trials only and exclusion of the studies with many unclear risk of bias characteristics. </p> <section id="CD004975-sec-0070"> <h4 class="title">1. All included studies</h4> <section id="CD004975-sec-0071"> <h5 class="title">Primary outcome</h5> <p><b>Clinical cure rate at the end of therapy</b> </p> <p>(<a href="#CD004975-tbl-0002">Table 2</a>; <a href="./references#CD004975-fig-0007" title="">Analysis 1.1</a>; <a href="#CD004975-fig-0003">Figure 3</a>) </p> <div class="figure" id="CD004975-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: Clinical cure rate at the end of therapy." data-id="CD004975-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: Clinical cure rate at the end of therapy.</p> </div> </div> </div> <div class="table" id="CD004975-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Clinical cure rate at the end of therapy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49/55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51/55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85 to 1.08</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27/33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23/34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91 to 1.60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>241/287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>229/288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.98 to 1.14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>212/231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>210/232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96 to 1.07</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187/199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>175/187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 to 1.06</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </div> <p>Five trials involving 1601 participants compared one or two daily doses of amoxicillin, with or without clavulanate, with three daily doses. The risk ratio (RR) showed comparable results between groups (RR 1.03, 95% confidence interval (CI) 0.99 to 1.07). </p> </section> <section id="CD004975-sec-0072"> <h5 class="title">Secondary outcomes</h5> <section id="CD004975-sec-0073"> <h6 class="title">Clinical cure rate during therapy</h6> <p>(<a href="#CD004975-tbl-0003">Table 3</a>; <a href="./references#CD004975-fig-0008" title="">Analysis 1.2</a>; <a href="#CD004975-fig-0004">Figure 4</a>) </p> <div class="figure" id="CD004975-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: Clinical cure rate during therapy." data-id="CD004975-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: Clinical cure rate during therapy.</p> </div> </div> </div> <div class="table" id="CD004975-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Clinical cure rate during therapy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30/30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28/33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.01 to 1.37</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48/199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45/186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80 to 1.25</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </div> <p>Two studies reported clinical cure during therapy and demonstrated a RR of 1.06 (95% CI 0.85 to 1.33) (<a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>). </p> </section> <section id="CD004975-sec-0074"> <h6 class="title">Clinical cure at post‐treatment (one to three months)</h6> <p>(<a href="#CD004975-tbl-0004">Table 4</a>; <a href="./references#CD004975-fig-0009" title="">Analysis 1.3</a>; <a href="#CD004975-fig-0005">Figure 5</a>) </p> <div class="figure" id="CD004975-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: Clinical cure at post‐treatment (one to three months)." data-id="CD004975-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: Clinical cure at post‐treatment (one to three months).</p> </div> </div> </div> <div class="table" id="CD004975-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Clinical cure rate at post‐treatment (1 to 3 months)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42/46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48/49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85 to 1.03</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>185/220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180/232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96 to 1.66</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>172/287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176/288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 to 1.15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>168/180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>153/174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.81 to 2.29</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </div> <p>Four trials reported clinical cure rate after therapy which showed no difference in either group (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>). The results were comparable (RR 1.02, 95% CI 0.95 to 1.09). </p> </section> <section id="CD004975-sec-0075"> <h6 class="title">AOM complications: Recurrent AOM after completion of therapy</h6> <p>(<a href="#CD004975-tbl-0005">Table 5</a>; <a href="./references#CD004975-fig-0010" title="">Analysis 1.4</a>; <a href="#CD004975-fig-0006">Figure 6</a>) </p> <div class="figure" id="CD004975-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: AOM complications: Recurrent AOM after completion of therapy." data-id="CD004975-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: AOM complications: Recurrent AOM after completion of therapy.</p> </div> </div> </div> <div class="table" id="CD004975-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">AOM complications: Recurrent AOM after completion of therapy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.48 to 35.95</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51/287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54/288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.78 to 1.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7/80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12/174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.64 to 2.2</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </div> <p>The pooled data from three studies showed a RR of 1.21 (95% CI 0.52 to 2.81) (<a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>). </p> </section> <section id="CD004975-sec-0076"> <h6 class="title">Adverse reactions to medication</h6> <p>(<a href="#CD004975-tbl-0006">Table 6</a>; <a href="#CD004975-tbl-0007">Table 7</a>; <a href="./references#CD004975-fig-0011" title="">Analysis 1.5</a>; <a href="./references#CD004975-fig-0012" title="">Analysis 1.6</a>; <a href="./references#CD004975-fig-0013" title="">Analysis 1.7</a>). </p> <div class="table" id="CD004975-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Overall adverse events</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111/231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94/232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97 to 1.46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37/206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.42 to 1.07</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </div> <div class="table" id="CD004975-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Specific adverse events to medication</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Diarrhoea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.06 to 16.40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16/287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20/288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42 to 1.52</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15/231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24/232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34 to 1.17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15/209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22/206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.3 to 1.28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Skin adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.19 to 5.19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23/287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30/288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46 to 1.29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.07 to 2.02</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </div> <p>The RR of overall adverse events between groups did not show any statistically significant difference (RR 0.92, 95% CI 0.52 to 1.63) (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>). </p> <p>Diarrhoea and skin adverse events were comparable (diarrhoea RR 0.70, 95% CI 0.49 to 1.00; skin RR 0.74; 95% CI 0.46 to 1.18) (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a>). </p> <p>Compliance rates were also reported in four trials (<a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a>; <a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a>; <a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a>; <a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a>). The pooled data showed no difference in compliance rate (RR 1.04, 95% CI 0.98 to 1.10) (<a href="#CD004975-tbl-0008">Table 8</a>; <a href="./references#CD004975-fig-0014" title="">Analysis 1.8</a>). </p> <div class="table" id="CD004975-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Compliance rate</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33/33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34/34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 to 1.06</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>257/287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>246/288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.99 to 1.12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>192/231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>169/232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03 to 1.26</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>173/209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>173/206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90 to 1.07</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </div> </section> </section> </section> <section id="CD004975-sec-0077"> <h4 class="title">2. Analysis of amoxicillin treatment trials only</h4> <p>The results are shown in <a href="./references#CD004975-fig-0015" title="">Analysis 2.1</a>; <a href="./references#CD004975-fig-0016" title="">Analysis 2.2</a>; <a href="./references#CD004975-fig-0017" title="">Analysis 2.3</a>; <a href="./references#CD004975-fig-0018" title="">Analysis 2.4</a>; <a href="./references#CD004975-fig-0021" title="">Analysis 2.7</a>; <a href="./references#CD004975-fig-0019" title="">Analysis 2.5</a> and <a href="./references#CD004975-fig-0020" title="">Analysis 2.6</a>, which are comparable for all outcomes. </p> </section> <section id="CD004975-sec-0078"> <h4 class="title">3. Analysis of amoxicillin/clavulanate treatment trials only</h4> <p>The results are shown in <a href="./references#CD004975-fig-0022" title="">Analysis 3.1</a>; <a href="./references#CD004975-fig-0023" title="">Analysis 3.2</a>; <a href="./references#CD004975-fig-0024" title="">Analysis 3.3</a>; <a href="./references#CD004975-fig-0025" title="">Analysis 3.4</a>; <a href="./references#CD004975-fig-0029" title="">Analysis 3.8</a>; <a href="./references#CD004975-fig-0026" title="">Analysis 3.5</a>; <a href="./references#CD004975-fig-0027" title="">Analysis 3.6</a> and <a href="./references#CD004975-fig-0028" title="">Analysis 3.7</a>, which are comparable for all outcomes. </p> </section> <section id="CD004975-sec-0079"> <h4 class="title">4. Exclusion of the studies with many unclear risk of bias characteristics</h4> <p>The study by <a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> had unclear risk of bias for random sequence generation, allocation concealment, blinding and 'other' bias. When we excluded this study from the analysis, both treatment groups still had comparable results (<a href="./references#CD004975-fig-0030" title="">Analysis 4.1</a>; <a href="./references#CD004975-fig-0031" title="">Analysis 4.2</a>; <a href="./references#CD004975-fig-0032" title="">Analysis 4.3</a>; <a href="./references#CD004975-fig-0033" title="">Analysis 4.4</a>; <a href="./references#CD004975-fig-0034" title="">Analysis 4.5</a>; <a href="./references#CD004975-fig-0035" title="">Analysis 4.6</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004975-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004975-sec-0080"></div> <p>Acute otitis media (AOM) is one of the most common infections for which antibacterial agents are prescribed for children in the United States (<a href="./references#CD004975-bbs2-0031" title="RoversMM , SchilderAG , ZielhuisGA , RosenfeldRM . Otitis media. Lancet2004;363:465‐73. [PUBMED: 14962529] ">Rovers 2004</a>). The diagnosis and management of AOM has a significant impact on the health of children, the cost of providing health care and the use of antibiotics. Although there has been much discussion surrounding the treatment of uncomplicated AOM using antibiotics or observation, antibiotics are still widely used. The first‐line antibiotic of choice for AOM is amoxicillin, with or without clavulanate (<a href="./references#CD004975-bbs2-0007" title="American Academy of Pediatrics Subcommittee. Diagnosis and management of acute otitis media. Pediatrics2004;113:1451‐65. [PUBMED: 15121972] ">AAPS 2004</a>). The effectiveness of antibiotics does not depend solely on their antimicrobial activity against the suspected pathogens, but also on factors such as dosage, appropriate dosing intervals, tolerability and palatability. One or two daily doses of oral antibiotics have a higher compliance rate than doses taken three times daily (<a href="./references#CD004975-bbs2-0022" title="KardasP . Comparison of patient compliance with once‐daily and twice‐daily antibiotic regimens in respiratory tract infections: results of a randomized trial. Journal of Antimicrobial Chemotherapy2007;59:531‐6. [PUBMED: 17289766] ">Kardas 2007</a>; <a href="./references#CD004975-bbs2-0027" title="PechereJC , HughesD , KardasP , CornagliaG . Non‐compliance with antibiotic therapy for acute community infections: a global survey. International Journal of Antimicrobial Agents2007;29:245‐53. [PUBMED: 17229552] ">Pechere 2007</a>). </p> <p>This systematic review demonstrated that when pooling all data from published trials of treatment with amoxicillin or amoxicillin/clavulanate for uncomplicated AOM in children, the results are comparable for all outcomes when comparing a once or twice daily dose with thrice daily doses. These results may show that both dosages have the same effectiveness or that uncomplicated AOM can self resolve. </p> <section id="CD004975-sec-0081"> <h3 class="title" id="CD004975-sec-0081">Summary of main results</h3> <p>This review identified five RCTs reporting clinical outcomes in children treated with one or two daily doses of amoxicillin, with or without clavulanate, compared to three daily doses. No trial used four daily doses. There were no significant statistical differences in the effectiveness of the two different dosages of amoxicillin, with or without clavulanate. </p> </section> <section id="CD004975-sec-0082"> <h3 class="title" id="CD004975-sec-0082">Overall completeness and applicability of evidence</h3> <p>This review demonstrates that both one or two daily doses of amoxicillin or amoxicillin/clavulanate have comparable effectiveness for the treatment of uncomplicated AOM in children. One or two daily doses might increase compliance in daily practice. </p> </section> <section id="CD004975-sec-0083"> <h3 class="title" id="CD004975-sec-0083">Quality of the evidence</h3> <p>All of the included studies had an unclear risk of bias for allocation concealment and three studies had an unclear risk of bias for randomisation as they did not describe the details of randomisation sequence generation or methods to conceal allocation. </p> </section> <section id="CD004975-sec-0084"> <h3 class="title" id="CD004975-sec-0084">Potential biases in the review process</h3> <p>We have not identified any potential biases in the review process.</p> </section> <section id="CD004975-sec-0085"> <h3 class="title" id="CD004975-sec-0085">Agreements and disagreements with other studies or reviews</h3> <p>There have been no other published studies or reviews comparing the two dosages of amoxicillin, with or without clavulanate, for the treatment of AOM. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004975-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004975-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of the five trials included." data-id="CD004975-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Funnel plot of the five trials included.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: Clinical cure rate at the end of therapy." data-id="CD004975-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: Clinical cure rate at the end of therapy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: Clinical cure rate during therapy." data-id="CD004975-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: Clinical cure rate during therapy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: Clinical cure at post‐treatment (one to three months)." data-id="CD004975-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: Clinical cure at post‐treatment (one to three months).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: AOM complications: Recurrent AOM after completion of therapy." data-id="CD004975-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: AOM complications: Recurrent AOM after completion of therapy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 One or two daily doses versus three daily doses, Outcome 1 Clinical cure rate at the end of therapy." data-id="CD004975-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 One or two daily doses versus three daily doses, Outcome 1 Clinical cure rate at the end of therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 One or two daily doses versus three daily doses, Outcome 2 Clinical cure rate during therapy." data-id="CD004975-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 One or two daily doses versus three daily doses, Outcome 2 Clinical cure rate during therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 One or two daily doses versus three daily doses, Outcome 3 Clinical cure rate at post‐treatment." data-id="CD004975-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 One or two daily doses versus three daily doses, Outcome 3 Clinical cure rate at post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 One or two daily doses versus three daily doses, Outcome 4 AOM complications: Recurrent AOM after completion of therapy." data-id="CD004975-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 One or two daily doses versus three daily doses, Outcome 4 AOM complications: Recurrent AOM after completion of therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 One or two daily doses versus three daily doses, Outcome 5 Adverse reactions to medication (overall)." data-id="CD004975-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 One or two daily doses versus three daily doses, Outcome 5 Adverse reactions to medication (overall). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 One or two daily doses versus three daily doses, Outcome 6 Specific adverse reactions to medication: Diarrhoea." data-id="CD004975-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 One or two daily doses versus three daily doses, Outcome 6 Specific adverse reactions to medication: Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 One or two daily doses versus three daily doses, Outcome 7 Specific reactions to medication: Skin adverse events." data-id="CD004975-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 One or two daily doses versus three daily doses, Outcome 7 Specific reactions to medication: Skin adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 One or two daily doses versus three daily doses, Outcome 8 Compliance rate." data-id="CD004975-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 One or two daily doses versus three daily doses, Outcome 8 Compliance rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 1 Clinical cure rate at the end of therapy." data-id="CD004975-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 1 Clinical cure rate at the end of therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 2 Clinical cure rate during therapy." data-id="CD004975-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 2 Clinical cure rate during therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 3 Clinical cure rate at post‐treatment." data-id="CD004975-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 3 Clinical cure rate at post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 4 AOM complications: Recurrent AOM after completion of therapy." data-id="CD004975-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 4 AOM complications: Recurrent AOM after completion of therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 5 Specific adverse reactions to medication: Diarrhoea." data-id="CD004975-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 5 Specific adverse reactions to medication: Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 6 Specific adverse reactions to medication: Skin adverse events." data-id="CD004975-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 6 Specific adverse reactions to medication: Skin adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 7 Compliance rate." data-id="CD004975-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Analysis for amoxicillin treatment trials only, Outcome 7 Compliance rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 1 Clinical cure rate at the end of therapy." data-id="CD004975-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 1 Clinical cure rate at the end of therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 2 Clinical cure rate during therapy." data-id="CD004975-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 2 Clinical cure rate during therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 3 Clinical cure rate at post‐treatment." data-id="CD004975-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 3 Clinical cure rate at post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 4 AOM complications: Recurrent AOM after completion of therapy." data-id="CD004975-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 4 AOM complications: Recurrent AOM after completion of therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 5 Adverse reactions to medication: Overall." data-id="CD004975-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 5 Adverse reactions to medication: Overall. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 6 Specific adverse reactions of medication: Diarrhoea." data-id="CD004975-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 6 Specific adverse reactions of medication: Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 7 Specific adverse reactions to medication: Skin adverse events." data-id="CD004975-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 7 Specific adverse reactions to medication: Skin adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 8 Compliance rate." data-id="CD004975-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Analysis for amoxicillin/clavulanate treatment trials only, Outcome 8 Compliance rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986), Outcome 1 Clinical cure rate at the end of therapy." data-id="CD004975-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986), Outcome 1 Clinical cure rate at the end of therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986), Outcome 2 Clinical cure rate during therapy." data-id="CD004975-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986), Outcome 2 Clinical cure rate during therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986), Outcome 3 AOM complications: Recurrent AOM after completion of therapy." data-id="CD004975-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986), Outcome 3 AOM complications: Recurrent AOM after completion of therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986), Outcome 4 Adverse reactions to medication: Overall adverse events." data-id="CD004975-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986), Outcome 4 Adverse reactions to medication: Overall adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986), Outcome 5 Specific adverse reactions to medication: Diarrhoea." data-id="CD004975-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986), Outcome 5 Specific adverse reactions to medication: Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004975-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/urn:x-wiley:14651858:media:CD004975:CD004975-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_t/tCD004975-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986), Outcome 6 Specific adverse events to medication: Skin adverse events." data-id="CD004975-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986), Outcome 6 Specific adverse events to medication: Skin adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/media/CDSR/CD004975/image_n/nCD004975-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD004975-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Quality assessment for individual trials</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Randomisation process</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Allocation concealment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Blinding</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incomplete outcome data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective reporting</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Other bias</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Drop‐outs</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.8% to 8.2%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.2% to 5.6%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.7% to 11%</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Quality assessment for individual trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004975-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Clinical cure rate at the end of therapy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49/55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51/55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85 to 1.08</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27/33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23/34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91 to 1.60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>241/287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>229/288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.98 to 1.14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>212/231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>210/232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96 to 1.07</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187/199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>175/187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 to 1.06</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Clinical cure rate at the end of therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004975-tbl-0003"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Clinical cure rate during therapy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30/30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28/33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.01 to 1.37</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48/199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45/186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80 to 1.25</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Clinical cure rate during therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004975-tbl-0004"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Clinical cure rate at post‐treatment (1 to 3 months)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42/46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48/49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85 to 1.03</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>185/220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180/232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96 to 1.66</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>172/287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176/288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 to 1.15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>168/180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>153/174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.81 to 2.29</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Clinical cure rate at post‐treatment (1 to 3 months)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004975-tbl-0005"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">AOM complications: Recurrent AOM after completion of therapy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.48 to 35.95</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51/287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54/288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.78 to 1.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7/80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12/174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.64 to 2.2</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">AOM complications: Recurrent AOM after completion of therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004975-tbl-0006"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Overall adverse events</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111/231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94/232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97 to 1.46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37/206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.42 to 1.07</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Overall adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004975-tbl-0007"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Specific adverse events to medication</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Diarrhoea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.06 to 16.40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16/287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20/288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42 to 1.52</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15/231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24/232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34 to 1.17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15/209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22/206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.3 to 1.28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Skin adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0005" title="PrincipiN , MarchisioP , BigalliL , MassironiE . Amoxicillin twice daily in the treatment of acute otitis media in infants and children. European Journal of Pediatrics1986;145(6):522‐5. ">Principi 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.19 to 5.19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23/287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30/288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46 to 1.29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.07 to 2.02</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Specific adverse events to medication</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004975-tbl-0008"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Compliance rate</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>One or two daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Three daily doses (n/N)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0004" title="MurphJR , DusdiekerLB , BoothB , MurphWE . Is treatment of acute otitis media with once‐a‐day amoxicillin feasible? Results of a pilot study. Clinical Pediatrics1993;32(9):528‐34. ">Murph 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33/33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34/34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 to 1.06</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0003" title="HobermanA , ParadiseJL , BurchDJ , ValinskiWA , HedrickJA , AronovitzGH , et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatric Infectious Diseases Journal1997;16(5):463‐70. ">Hoberman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>257/287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>246/288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.99 to 1.12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0001" title="BehreU , BurowHM , QuinnP , CreeF , HarrisonHE . Efficacy of twice‐daily dosing of amoxycillin/clavulanate in acute otitis media in children. Infection1997;25(3):163‐6. ">Behre 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>192/231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>169/232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03 to 1.26</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004975-bbs2-0002" title="DamrikarnlertL , JaureguiAC , KzadriM . Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Journal of Chemotherapy2000;12(1):78‐97. ">Damrikarnlert 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>173/209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>173/206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90 to 1.07</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Compliance rate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/full#CD004975-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004975-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">One or two daily doses versus three daily doses</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical cure rate at the end of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1601</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.99, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical cure rate during therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>448</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.85, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical cure rate at post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1476</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.95, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 AOM complications: Recurrent AOM after completion of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1029</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.52, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adverse reactions to medication (overall) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>878</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.52, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Specific adverse reactions to medication: Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1563</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.49, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Specific reactions to medication: Skin adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.46, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Compliance rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1520</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.98, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">One or two daily doses versus three daily doses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004975-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Analysis for amoxicillin treatment trials only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical cure rate at the end of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.82, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical cure rate during therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [1.01, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical cure rate at post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.85, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 AOM complications: Recurrent AOM after completion of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.16 [0.48, 35.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Specific adverse reactions to medication: Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Specific adverse reactions to medication: Skin adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.21, 4.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Compliance rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.94, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Analysis for amoxicillin treatment trials only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004975-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Analysis for amoxicillin/clavulanate treatment trials only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical cure rate at the end of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1424</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.99, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical cure rate during therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.70, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical cure rate at post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1381</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.98, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 AOM complications: Recurrent AOM after completion of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>929</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.39, 2.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adverse reactions to medication: Overall <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>878</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.52, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Specific adverse reactions of medication: Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.48, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Specific adverse reactions to medication: Skin adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.44, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Compliance rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.98, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Analysis for amoxicillin/clavulanate treatment trials only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004975-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical cure rate at the end of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1491</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.99, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical cure rate during therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1381</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.98, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 AOM complications: Recurrent AOM after completion of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>929</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.39, 2.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse reactions to medication: Overall adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>878</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.52, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Specific adverse reactions to medication: Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.48, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Specific adverse events to medication: Skin adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.44, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Analysis excluding the studies with many unclear risk of bias characteristics (Principi 1986)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004975.pub3/references#CD004975-tbl-0012">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004975.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004975-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004975-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD004975-note-0001">Français</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004975\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004975\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004975\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004975\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004975\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=k5rEBE5b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004975.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004975.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004975.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004975.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004975.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740711487045"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004975.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740711487049"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004975.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d26a4ac579377',t:'MTc0MDcxMTQ4Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 